93 related articles for article (PubMed ID: 7954241)
1. Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5-fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin-3.
Theodossiou C; Kroog G; Ettinghausen S; Tolcher A; Cowan K; O'Shaughnessy J
Cancer; 1994 Nov; 74(10):2808-10. PubMed ID: 7954241
[TBL] [Abstract][Full Text] [Related]
2. Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: a report of two cases.
Tolcher AW; Giusti RM; O'Shaughnessy JA; Cowan KH
Cancer Invest; 1995; 13(2):188-92. PubMed ID: 7874573
[TBL] [Abstract][Full Text] [Related]
3. Acute abdomen during adjuvant chemotherapy: superior mesenteric artery thrombosis associated with CMF chemotherapy.
Sugden EM; Griffiths CL; Greywoode GI; Lewis SM
Clin Oncol (R Coll Radiol); 2001; 13(6):441-3. PubMed ID: 11824882
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast cancer.
Jones SE; Khandelwal P; McIntyre K; Mennel R; Orr D; Kirby R; Agura E; Duncan L; Hyman W; Roque T; Regan D; Schuster M; Dimitrov N; Garrison L; Lange M
J Clin Oncol; 1999 Oct; 17(10):3025-32. PubMed ID: 10506596
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma.
Parnes HL; Abrams JS; Tait N; Minford J; Allen SL; Duggan D; Aisner J
J Natl Cancer Inst; 1991 Jul; 83(14):1017-20. PubMed ID: 2072408
[TBL] [Abstract][Full Text] [Related]
6. Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study.
Wall JG; Weiss RB; Norton L; Perloff M; Rice MA; Korzun AH; Wood WC
Am J Med; 1989 Nov; 87(5):501-4. PubMed ID: 2510514
[TBL] [Abstract][Full Text] [Related]
7. Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group study.
Ellis GK; Green S; Schulman S; Coltman CA; Hynes HE; Rivkin S; Livingston RB
Cancer; 1991 Sep; 68(5):934-9. PubMed ID: 1913489
[TBL] [Abstract][Full Text] [Related]
8. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.
Levine MN; Gent M; Hirsh J; Arnold A; Goodyear MD; Hryniuk W; De Pauw S
N Engl J Med; 1988 Feb; 318(7):404-7. PubMed ID: 3340118
[TBL] [Abstract][Full Text] [Related]
9. Successful thrombolysis of SVC thrombosis associated with Hickman lines and continuous infusion chemotherapy.
Bissett D; Kaye SB; Baxter G; Moss J
Clin Oncol (R Coll Radiol); 1996; 8(4):247-9. PubMed ID: 8871003
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
11. Cerebral venous sinus thrombosis in a patient receiving adjuvant chemotherapy for stage II breast cancer through an implanted central venous catheter.
Holmes FA; Obbens EA; Griffin E; Lee YY
Am J Clin Oncol; 1987 Aug; 10(4):362-6. PubMed ID: 3039833
[No Abstract] [Full Text] [Related]
12. Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
Parnes HL; Cirrincione C; Aisner J; Berry DA; Allen SL; Abrams J; Chuang E; Cooper MR; Perry MC; Duggan DB; Szatrowski TP; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1819-24. PubMed ID: 12721259
[TBL] [Abstract][Full Text] [Related]
13. Fatal acute tumor lysis syndrome with metastatic breast carcinoma.
Stark ME; Dyer MC; Coonley CJ
Cancer; 1987 Aug; 60(4):762-4. PubMed ID: 3594399
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancer.
Sparano JA; Wadler S; Liebes L; Robert NJ; Schwartz EL; Dutcher JP
Cancer Res; 1993 Aug; 53(15):3509-12. PubMed ID: 8339255
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.
Jones SE; Schottstaedt MW; Duncan LA; Kirby RL; Good RH; Mennel RG; George TK; Snyder DA; Watkins DL; Denham CA; Hoyes FA; Rubin AS
J Clin Oncol; 1996 Nov; 14(11):2976-83. PubMed ID: 8918495
[TBL] [Abstract][Full Text] [Related]
16. [Medroxyprogesterone acetate for treatment of advanced breast cancers].
Mitsuyama S; Anan K
Nihon Rinsho; 2000 Apr; 58 Suppl():317-21. PubMed ID: 11026012
[No Abstract] [Full Text] [Related]
17. High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.
Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Nagasawa S
Cancer; 1994 Mar; 73(6):1678-85. PubMed ID: 7512436
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer.
Akhtar MS; Kousar F; Masood M; Fatimi S; Kokab
J Coll Physicians Surg Pak; 2010 Nov; 20(11):748-52. PubMed ID: 21078249
[TBL] [Abstract][Full Text] [Related]
19. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
